FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Fishbane

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Phenomena

Hematocrit

Co-author Network

Publications

TOP 3
Iain C Macdougall; Steven Fishbane; Anne-Marie Duliege
Peginesatide for anemia in chronic kidney disease.
Steven Fishbane; Edouard Martin; Janet O'Neil; Ping Qiu; Simon D Roger; Grant Runyan; Francesco Locatelli
Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa.
Iain C Macdougall; Martha R Mayo; Pablo E Pergola; Krishna R Polu; Robert Provenzano; Rebecca J Schmidt; Amit Sharma; Bruce S Spinowitz; Hong Tang; Sandra Tong-Starksen; Raja I Zabaneh; Anne-Marie Duliege; Steven Fishbane
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Fishbane (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Iain C Macdougall; Steven Fishbane; Anne-Marie Duliege
Peginesatide for anemia in chronic kidney disease.
The New England journal of medicine 2013;368(16):1553-4.
2013: Steven Fishbane; Edouard Martin; Janet O'Neil; Ping Qiu; Simon D Roger; Grant Runyan; Francesco Locatelli
Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa.
Clinical journal of the American Society of Nephrology : CJASN 2013;8(4):538-45.
2013: Iain C Macdougall; Martha R Mayo; Pablo E Pergola; Krishna R Polu; Robert Provenzano; Rebecca J Schmidt; Amit Sharma; Bruce S Spinowitz; Hong Tang; Sandra Tong-Starksen; Raja I Zabaneh; Anne-Marie Duliege; Steven Fishbane
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.
The New England journal of medicine 2013;368(4):320-32.
2013: Steven Fishbane; Carol Francisco; Mark Kaplan; Nathan W Levin; Francesco Locatelli; Iain C Macdougall; Martha R Mayo; Krishna R Polu; Robert Provenzano; Brigitte Schiller; Andrzej Wiecek; Anatole Besarab; Adrian C Covic; Anne-Marie Duliege
Peginesatide in patients with anemia undergoing hemodialysis.
The New England journal of medicine 2013;368(4):307-19.
2013: Allison Tong; Jonathan C Craig; Steven Fishbane; Letizia Gargano; Jörgen Hegbrant; David W Johnson; Braden Manns; Måns Olsson; Suetonia Palmer; Marinella Ruospo; G F M Strippoli
The beliefs and expectations of patients and caregivers about home haemodialysis: an interview study.
BMJ open 2013;3(1):.
2012: Steven Fishbane; Azzour D Hazzan; Ezra Israel; Shayan Shirazian; Giovanni F Strippoli
Quality of reporting of randomization methodology in nephrology trials.
Kidney international 2012;82(11):1144-6.
2012: Steven Fishbane; Azzour Hazzan
Meeting the 2012 QIP (Quality Incentive Program) clinical measures: strategies for dialysis centers.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2012;60(5 Suppl 1):S5-13; quiz S14-7.
2012: Steven Fishbane; Ashish Kataria; Hitesh H Shah; Shayan Shirazian; Rajiv Agarwal
Subgroup analyses in nephrology clinical trials.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(11):1872-6.
2012: Steven Fishbane; Zhu Li; William Strauss; Wolfgang C Winkelmayer; W Kline Bolton; Brian J G Pereira
Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients.
Clinical nephrology 2012;78(3):181-8.
2012: Steven Fishbane; Naveed N Masani; Ilene Miller; Helen Danko; Lenore Bruno
Interpreting changes to the ESRD quality incentive program.
Nephrology news & issues 2012;26(9):22-4, 26-9.
2012: Steven Fishbane; Jay B Wish
A physician's perseverance uncovers problems in a key nephrology study.
Kidney international 2012;82(2):135-7.
2012: Shayan Shirazian; Liliana Rios-Rojas; Daniel J Cho; Sudharani Dikkala; James Drakakis; Marc Duey; Paula Dutka; Steven Fishbane
The effect of hemodialysis ultrafiltration on changes in whole blood viscosity.
Hemodialysis international. International Symposium on Home Hemodialysis 2012;16(3):342-50.
2012: Steven Fishbane; Ilene Miller; John D Wagner; Naveed N Masani
Changes to the end-stage renal disease quality incentive program.
Kidney international 2012;81(12):1167-71.
2012: Steven Fishbane; Kenar D Jhaveri
The new label for erythropoiesis stimulating agents: the FDA'S sentence.
Seminars in dialysis 2012;25(3):263-6.
2012: Alan S Kliger; Steven Fishbane; Fredric O Finkelstein
Erythropoietic stimulating agents and quality of a patient's life: individualizing anemia treatment.
Clinical journal of the American Society of Nephrology : CJASN 2012;7(2):354-7.
2012: Allison Tong; Jonathan C Craig; Steven Fishbane; Letizia Gargano; Jörgen Hegbrant; David W Johnson; Braden Manns; Måns Olsson; Suetonia Palmer; Marinella Ruospo; G F M Strippoli
Clinician beliefs and attitudes about home haemodialysis: a multinational interview study.
BMJ open 2012;2(6):.
2012: Steven Fishbane; Helen Danko; Ilene Miller; Naveed Masani
The QIP: will it improve dialysis care? An overview.
Nephrology news & issues 2012;26(1):20, 22-4, 26.
2011: Steven Fishbane; Samuel L Milligan; Kenneth D Lempert; Joachim E W Hertel; James B Wetmore; Matthew J Oliver; Martha Blaney; Barbara S Gillespie; Joan R Jacobs; Susan M Begelman
Improvement of hemodialysis catheter function with tenecteplase: a phase III, open-label study: TROPICS 4.
Journal of thrombosis and thrombolysis 2011;31(1):99-106.
2010: Steven Fishbane; Nobuyuki Miyawaki; Lynda A Szczech
Hypothesis: an erythropoietin honeymoon phase exists.
Kidney international 2010;78(7):646-9.
2010: Steven Fishbane; Allen R Nissenson
Anemia management in chronic kidney disease.
Kidney international. Supplement 2010;(117):S3-9.
2010: Steven Fishbane
The role of erythropoiesis-stimulating agents in the treatment of anemia.
The American journal of managed care 2010;16 Suppl Issues():S67-73.
2010: Steven Fishbane; Nobuyuki Miyawaki
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure.
Kidney international 2010;77(3):175-7.
2010: Steven Fishbane; James Delmez; Wadi N Suki; Srinivas K Hariachar; Jeremy Heaton; Scott Chasan-Taber; Melissa A Plone; Sharon Moe
A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing with thrice-daily sevelamer hydrochloride tablet dosing in CKD patients on hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2010;55(2):307-15.
2009: Shaffeeulah Bacchus; Neeta O'Mara; Harold Manley; Steven Fishbane
Meeting new challenges in the management of anemia of chronic kidney disease through collaborative care with pharmacists.
The Annals of pharmacotherapy 2009;43(11):1857-66.
2009: Steven Fishbane; Harini Chittineni; Michal Packman; Paula Dutka; Nicole Ali; Nicole Durie
Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2009;54(4):647-52.
2009: Steven Fishbane; David J Cohen; Daniel W Coyne; Arjang Djamali; Ajay K Singh; Jay B Wish
Posttransplant anemia: the role of sirolimus.
Kidney international 2009;76(4):376-82.
2009: Steven Fishbane; Ajay K Singh
Iron deficiency in non-dialysis chronic kidney disease.
Kidney international 2009;75(7):752-4.
2009: Steven Fishbane
Anemia in chronic kidney disease: status of new therapies.
Current opinion in nephrology and hypertension 2009;18(2):112-5.
2009: Solomon Bitew; Louis Imbriano; Nobuyuki Miyawaki; Steven Fishbane; John K Maesaka
More on renal salt wasting without cerebral disease: response to saline infusion.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(2):309-15.
2009: Steven Fishbane
Erythropoiesis-stimulating agent treatment with full anemia correction: a new perspective.
Kidney international 2009;75(4):358-65.
2009: Steven Fishbane; Simcha Pollack; Harold I Feldman; Marshall M Joffe
Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.
Clinical journal of the American Society of Nephrology : CJASN 2009;4(1):57-61.
2008: Steven Fishbane; Warren B Shapiro; Dalila B Corry; Steven L Vicks; Michael Roppolo; Kenneth Rappaport; Xiang Ling; William G Goodman; Stewart Turner; Chaim Charytan
Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(6):1718-25.
2008: Steven Fishbane
Anemia and cardiovascular risk in the patient with kidney disease.
Heart failure clinics 2008;4(4):401-10.
2008: Steven Fishbane; Kristin Larson; Suzann VanBuskirk
Stabilizing hemoglobin levels: what's new in IV iron and anemia management?
Nephrology nursing journal : journal of the American Nephrology Nurses' Association 2008;35(5):493-502.
2008: Rajnish Mehrotra; Kevin J Martin; Steven Fishbane; Stuart M Sprague; Steven Zeig; Michael Anger
Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(5):1437-45.
2008: Ajay K Singh; Edgar Milford; Steven Fishbane; Sai Ram Keithi-Reddy
Managing anemia in dialysis patients: hemoglobin cycling and overshoot.
Kidney international 2008;74(5):679-83.
2008: Ryan D Kilpatrick; Cathy W Critchlow; Steven Fishbane; Anatole Besarab; Catherine Stehman-Breen; Mahesh Krishnan; Brian D Bradbury
Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(4):1077-83.
2008: Steven M Brunelli; Marshall M Joffe; Rubeen K Israni; Wei Yang; Steven Fishbane; Jeffrey S Berns; Harold I Feldman
History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(3):777-82.
2008: Steven Fishbane
Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
Seminars in dialysis 2008;21(3):217-20.
2008: Ajay K Singh; Steven Fishbane
The optimal hemoglobin in dialysis patients- a critical review.
Seminars in dialysis 2008;21(1):1-6.
2008: Steven Fishbane
N-acetylcysteine in the prevention of contrast-induced nephropathy.
Clinical journal of the American Society of Nephrology : CJASN 2008;3(1):281-7.
2007: Wei Yang; Rubeen K Israni; Steven M Brunelli; Marshall M Joffe; Steven Fishbane; Harold I Feldman
Hemoglobin variability and mortality in ESRD.
Journal of the American Society of Nephrology : JASN 2007;18(12):3164-70.
2007: Steven Fishbane; Anne Pannier; Xavier Liogier; Paul Jordan; Frank C Dougherty; Bruno Reigner
Pharmacokinetic and pharmacodynamic properties of methoxy polyethylene glycol-epoetin beta are unaffected by the site of subcutaneous administration.
Journal of clinical pharmacology 2007;47(11):1390-7.
2007: Steven Fishbane; Anatole Besarab
Mechanism of increased mortality risk with erythropoietin treatment to higher hemoglobin targets.
Clinical journal of the American Society of Nephrology : CJASN 2007;2(6):1274-82.
2007: Nathan W Levin; Steven Fishbane; Francisco Valdés Cañedo; Steven Zeig; George M Nassar; John E Moran; Giuseppe Villa; Ulrich Beyer; Delphine Oguey
Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA).
Lancet 2007;370(9596):1415-21.
2007: Steven Fishbane; A R Nissenson
The new FDA label for erythropoietin treatment: how does it affect hemoglobin target?
Kidney international 2007;72(7):806-13.
2007: Steven Fishbane; Michael S Niederman; Colleen Daly; Adam Magin; Masateru Kawabata; André de Corla-Souza; Irum Choudhery; Gerald Brody; Maureen Gaffney; Simcha Pollack; Suzanne Parker
The impact of standardized order sets and intensive clinical case management on outcomes in community-acquired pneumonia.
Archives of internal medicine 2007;167(15):1664-9.
2007: Steven Fishbane; Jeffrey S Berns
Evidence and implications of haemoglobin cycling in anaemia management.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22(8):2129-32.
2007: Steven Fishbane
Iron management in nondialysis-dependent CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2007;49(6):736-43.
2007: Jeffrey S Berns; Steven Fishbane
CHOIR, CREATE, and anemia treatment in patients with CKD.
Seminars in dialysis 2007;20(3):277-9.
2007: Anatole Besarab; Moro O Salifu; N Martin Lunde; Vinod Bansal; Steven Fishbane; Frank C Dougherty; Ulrich Beyer
Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
Clinical therapeutics 2007;29(4):626-39.
2007: John K Maesaka; Nobuyuki Miyawaki; Thomas Palaia; Steven Fishbane; J H C Durham
Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia.
Kidney international 2007;71(8):822-6.
2007: Clarence P Alfrey; Steven Fishbane
Implications of neocytolysis for optimal management of anaemia in chronic kidney disease.
Nephron. Clinical practice 2007;106(4):c149-56.
2007: Vinay Nair; Michael S Niederman; Naveed N Masani; Steven Fishbane
Hyponatremia in community-acquired pneumonia.
American journal of nephrology 2007;27(2):184-90.
2007: Harini Chittineni; Nobuyuki Miyawaki; Sailaja Gulipelli; Steven Fishbane
Risk for acute renal failure in patients hospitalized for decompensated congestive heart failure.
American journal of nephrology 2007;27(1):55-62.
2007: Steven Fishbane
What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
Blood purification 2007;25(1):53-7.
2006: Peter Kotanko; Nathan W Levin; Steven Fishbane; Der-Cherng Tarng; Jeffrey S Berns
How can erythropoietin requirements be reduced in dialysis patients?
Seminars in dialysis 2006;19(5):363-72.
2006: Steven Fishbane
Iron supplementation in renal anemia.
Seminars in nephrology 2006;26(4):319-24.
2006: Jeffrey S Berns; Steven Fishbane
Hemoglobin variability: random fluctuation, epiphenomenon, or phenomenon?
Seminars in dialysis 2006;19(3):257-9.
2006: Steven Fishbane
Refractory anemia in a patient with allergy to intravenous iron drugs.
Kidney international 2006;69(10):1910-3.
2006: Steven Fishbane
EPO adjuvant treatments: a need for more evidence.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2006;47(4):683-5.
2006: Beckie Michael; Steven Fishbane; Daniel W Coyne; Rajiv Agarwal; David G Warnock
Drug insight: Safety of intravenous iron supplementation with sodium ferric gluconate complex.
Nature clinical practice. Nephrology 2006;2(2):92-100.
2006: Kathleen L Wyne; Steven Fishbane; Geoffrey A Block; Karen Warburton; Jeffrey S Berns; Alicia M Neu; Bradley A Warady
How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
Seminars in dialysis 2006;19(1):8-24.
2006: Steven Fishbane
Recombinant human erythropoietin: has treatment reached its full potential?
Seminars in dialysis 2006;19(1):1-4.
2005: Steven Fishbane; Jeffrey S Berns
Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin.
Kidney international 2005;68(3):1337-43.
2005: Jeffrey S Berns; Steven Fishbane; Hafez Elzein; Robert I Lynn; Peter B Deoreo; David L Tharpe; Ira S Meisels
The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients.
Hemodialysis international. International Symposium on Home Hemodialysis 2005;9(3):255-63.
2005: Steven Fishbane
Cardiovascular risk evaluation before kidney transplantation.
Journal of the American Society of Nephrology : JASN 2005;16(4):843-5.
2004: Steven Fishbane; Nobuyuki Miyawaki; Naveed N Masani
Hepatic iron in hemodialysis patients.
Kidney international 2004;66(4):1714-5.
2004: Steven Fishbane; Kamyar Kalantar-Zadeh; Allen R Nissenson
Serum ferritin in chronic kidney disease: reconsidering the upper limit for iron treatment.
Seminars in dialysis 2004;17(5):336-41.
2004: Steven Fishbane; John H Durham; Kevin Marzo; Michael Rudnick
N-acetylcysteine in the prevention of radiocontrast-induced nephropathy.
Journal of the American Society of Nephrology : JASN 2004;15(2):251-60.
2004: Steven Fishbane; Louis Ragolia; Thomas Palaia; Barbra Johnson; Hafez Elzein; John K Maesaka
Cytoprotection by darbepoetin/epoetin alfa in pig tubular and mouse mesangial cells.
Kidney international 2004;65(2):452-8.
2003: Maria V DeVita; D Frumkin; S Mittal; A Kamran; Steven Fishbane; Michael F Michelis
Targeting higher ferritin concentrations with intravenous iron dextran lowers erythropoietin requirement in hemodialysis patients.
Clinical nephrology 2003;60(5):335-40.
2003: Jeffrey S Berns; Hafez Elzein; Robert I Lynn; Steven Fishbane; Ira S Meisels; Peter B Deoreo
Hemoglobin variability in epoetin-treated hemodialysis patients.
Kidney international 2003;64(4):1514-21.
2003: Steven Fishbane
Safety in iron management.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(5 Suppl):18-26.
2003: Steven Fishbane
Safety issues with iron sucrose.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(4):899; author reply 900.
2003: Daniel W Coyne; N FRANKLIN ADKINSON; Allen R Nissenson; Steven Fishbane; Rajiv Agarwal; Joseph W Eschbach; Beckie Michael; Vaughn W Folkert; Daniel Batlle; J Richard Trout; Naomi V Dahl; Pamela Myirski; Jur Strobos; David G Warnock
Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
Kidney international 2003;63(1):217-24.
2002: John D Durham; Christopher Caputo; John Dokko; Thomas Zaharakis; Mohsen Pahlavan; Jan Keltz; Paula Dutka; Kevin Marzo; John K Maesaka; Steven Fishbane
A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography.
Kidney international 2002;62(6):2202-7.
2002: Steven Fishbane
Anemia treatment in chronic renal insufficiency.
Seminars in nephrology 2002;22(6):474-8.
2002: John K Maesaka; Thomas Palaia; Steven Fishbane; Louis Ragolia
Contribution of prostaglandin D2 synthase to progression of renal failure and dialysis dementia.
Seminars in nephrology 2002;22(5):407-14.
2002: Christopher Caputo; Steven Fishbane; Lawrence Shapiro; Robert G Courgi; Stefan Kostadinov; Virginia Donovan; David Epstein
Pheochromocytoma multisystem crisis in a patient with multiple endocrine neoplasia type IIB and pyelonephritis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(6):E23.
2002: Steven Fishbane
Review: recombinant human erythropoietin decreases the need for blood transfusions and may delay dialysis in chronic renal failure.
ACP journal club 2002;136(3):85.
2002: George M Nassar; Steven Fishbane; Juan Carlos Ayus
Occult infection of old nonfunctioning arteriovenous grafts: a novel cause of erythropoietin resistance and chronic inflammation in hemodialysis patients.
Kidney international. Supplement 2002;(80):49-54.
2002: Beckie Michael; Daniel W Coyne; Steven Fishbane; Vaughn W Folkert; Robert Lynn; Allen R Nissenson; Rajiv Agarwal; Joseph W Eschbach; Stephen Z Fadem; J Richard Trout; Jur Strobos; David G Warnock
Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
Kidney international 2002;61(5):1830-9.
2002: Steven Fishbane; Richard Goldman
Quality outcomes and obstacles to their achievement in end-stage renal disease.
Seminars in dialysis 2002;15(1):30-4.
2001: Steven Fishbane; W Shapiro; P Dutka; O F Valenzuela; J Faubert
A randomized trial of iron deficiency testing strategies in hemodialysis patients.
Kidney international 2001;60(6):2406-11.
2001: John K Maesaka; Thomas Palaia; L Frese; Steven Fishbane; Louis Ragolia
Prostaglandin D(2) synthase induces apoptosis in pig kidney LLC-PK1 cells.
Kidney international 2001;60(5):1692-8.
2001: Louis Ragolia; Thomas Palaia; L Frese; Steven Fishbane; John K Maesaka
Prostaglandin D2 synthase induces apoptosis in PC12 neuronal cells.
Neuroreport 2001;12(12):2623-8.
2001: SK Mittal; L Ahern; ER Flaster; John K Maesaka; Steven Fishbane
Self-assessed physical and mental function of haemodialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2001;16(7):1387-94.
2001: SK Mittal; L Ahern; ER Flaster; V S Mittal; John K Maesaka; Steven Fishbane
Self-assessed quality of life in peritoneal dialysis patients.
American journal of nephrology 2001;21(3):215-20.
2001: Steven Fishbane; John Wagner
Sodium ferric gluconate complex in the treatment of iron deficiency for patients on dialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;37(5):879-83.
2000: Steven Fishbane; E A Kowalski
The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate.
Seminars in dialysis 2000;13(6):381-4.
1999: Steven Fishbane; John K Maesaka; SK Mittal
Is there material hazard to treatment with intravenous iron?
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1999;14(11):2595-8.
1999: Steven Fishbane
Review of issues relating to iron and infection.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(4 Suppl 2):S47-52.
1999: John K Maesaka; S Gupta; Steven Fishbane
Cerebral salt-wasting syndrome: does it exist?
Nephron 1999;82(2):100-9.
1999: John K Maesaka; Thomas Palaia; S A Chowdhury; T Shimamura; Steven Fishbane; W Reichman; A Coyne; J J O'Rear; M E El-Sabban
Partial characterization of apoptotic factor in Alzheimer plasma.
The American journal of physiology 1999;276(4 Pt 2):F521-7.
1999: Steven Fishbane; SK Mittal; John K Maesaka
Beneficial effects of iron therapy in renal failure patients on hemodialysis.
Kidney international. Supplement 1999;69():S67-70.
1998: Steven Fishbane
Iron treatment: impact of safety issues.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(6 Suppl 4):S152-6.
1998: Steven Fishbane
Intravenous infusion of total dose iron in peritoneal dialysis patients: a critical appraisal.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(6):1086-8; discussion 1088-90.
1998: John K Maesaka; Steven Fishbane
Regulation of renal urate excretion: a critical review.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;32(6):917-33.
1997: Steven Fishbane; C Galgano; R C Langley; W Canfield; John K Maesaka
Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients.
Kidney international 1997;52(1):217-22.
1997: John K Maesaka; SK Mittal; Steven Fishbane
Paraneoplastic syndromes of the kidney.
Seminars in oncology 1997;24(3):373-81.
1997: Steven Fishbane; John K Maesaka
Iron management in end-stage renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(3):319-33.
1997: Steven Fishbane; John K Maesaka
Current issues in iron management in end-stage renal disease.
Seminars in dialysis 1997;10(1):5-8.
1996: Steven Fishbane; E A Kowalski; L J Imbriano; John K Maesaka
The evaluation of iron status in hemodialysis patients.
Journal of the American Society of Nephrology : JASN 1996;7(12):2654-7.
1996: Steven Fishbane; V D Ungureanu; John K Maesaka; C J Kaupke; V Lim; J Wish
The safety of intravenous iron dextran in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(4):529-34.
1996: J C Ruggian; John K Maesaka; Steven Fishbane
Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(3):409-14.
1996: Steven Fishbane; E Natke; John K Maesaka
Role of volume overload in dialysis-refractory hypertension.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;28(2):257-61.
1996: Steven Fishbane; S Youn; ER Flaster; G Adam; John K Maesaka
Ankle-arm blood pressure index as a predictor of mortality in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1996;27(5):668-72.
1996: J C Ruggian; Steven Fishbane; F J Demento; John K Maesaka; G L Frei
Porphyria cutanea tarda in a patient on chronic ambulatory peritoneal dialysis.
Journal of the American Society of Nephrology : JASN 1996;7(3):397-402.
1995: Steven Fishbane; R I Lynn
The efficacy of iron dextran for the treatment of iron deficiency in hemodialysis patients.
Clinical nephrology 1995;44(4):238-40.
1995: Steven Fishbane; G L Frei; John K Maesaka
Reduction in recombinant human erythropoietin doses by the use of chronic intravenous iron supplementation.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;26(1):41-6.
1995: Steven Fishbane; R I Lynn
The utility of zinc protoporphyrin for predicting the need for intravenous iron therapy in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;25(3):426-32.
1995: Steven Fishbane; G L Frei; M Finger; R Dressler; Sharon Silbiger
Hypervitaminosis A in two hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;25(2):346-9.
1995: Steven Fishbane; S Youn; E J Kowalski; G L Frei
Ankle-arm blood pressure index as a marker for atherosclerotic vascular diseases in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1995;25(1):34-9.
1995: R I Lynn; Steven Fishbane; N S Ginsberg
The effect of KT/V(urea) on nitrogen appearance and appetite in peritoneal dialysis.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1995;15(5 Suppl):S50-2.